Flex-a-min
Natural health product licensed in Canada
- Licence holder
- Arthritis Research Corp.
- NPN or DIN-HM
- 80003968
- Status
- Active licence
- Licence date
- 30 August 2007
- Revision date
- Not provided
- Form
- Comprimé enrobé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly-(1->3)-N-aceltyl-2-amino-2-deoxy-3-O-beta-D-glucopyranurosyl-4-(or 6-)sulfonyl-D-galactose | 400 mg | Not calculated |
| Sulfate de glucosamine | 377 mg | Not calculated |
Non-medicinal ingredients
cellulose, Dioxyde de titane, Stéarate de magnésium végétal, Crospovidone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For seniors desiring maximum joint and cartilage maintenance. For weekend athletes or those with joint discomfort from physical activity. For overnight individuals looking for supplement support for over stressed joints and cartilage. For anyone desiring extra nutritional support for joint discomfort. Helps in the formation of connective tissue. Helps relieve symptoms of bone and joint pain. Helps to relieve pain due to osteoarthritis. Factor in the building of healthy cartilage. Effective in reducing joint pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80003968
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.